BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 22361334)

  • 1. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
    Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells.
    Takahashi H; Numasaki M; Lotze MT; Sasaki H
    Immunol Lett; 2005 May; 98(2):189-93. PubMed ID: 15860217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
    Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
    Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism and role of endothelial monocyte chemoattractant protein-1 induction by vascular endothelial growth factor.
    Yamada M; Kim S; Egashira K; Takeya M; Ikeda T; Mimura O; Iwao H
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):1996-2001. PubMed ID: 14500291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
    Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF165) plus basic fibroblast growth factor (bFGF) producing cells induce a mature and stable vascular network--a future therapy for ischemically challenged tissue.
    Spanholtz TA; Theodorou P; Holzbach T; Wutzler S; Giunta RE; Machens HG
    J Surg Res; 2011 Nov; 171(1):329-38. PubMed ID: 20605609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol Promotes Angiogenesis and Increases Cell Proliferation After Myocardial Ischemia-Reperfusion Injury Through a cAMP-Dependent Mechanism.
    Li J; Xiang X; Xu H; Shi Y
    Cardiovasc Eng Technol; 2019 Dec; 10(4):638-647. PubMed ID: 31625080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey.
    Wei P; Yu FQ; Chen XL; Tao SX; Han CS; Liu YX
    Placenta; 2004; 25(2-3):184-96. PubMed ID: 14972451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor is a major mediator in heparin-induced angiogenesis.
    Okada M; Matsumori A; Ono K; Miyamoto T; Takahashi M; Sasayama S
    Biochem Biophys Res Commun; 1999 Feb; 255(1):80-7. PubMed ID: 10082659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor.
    Nakamura Y; Morishita R; Higaki J; Kida I; Aoki M; Moriguchi A; Yamada K; Hayashi S; Yo Y; Nakano H; Matsumoto K; Nakamura T; Ogihara T
    J Hypertens; 1996 Sep; 14(9):1067-72. PubMed ID: 8986905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.
    Hu W; Criswell MH; Fong SL; Temm CJ; Rajashekhar G; Cornell TL; Clauss MA
    Exp Eye Res; 2009 Jan; 88(1):79-91. PubMed ID: 19013152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
    Tsubaki M; Yamazoe Y; Yanae M; Satou T; Itoh T; Kaneko J; Kidera Y; Moriyama K; Nishida S
    Cytokine; 2011 Apr; 54(1):100-7. PubMed ID: 21292498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
    Schmidt NO; Westphal M; Hagel C; Ergün S; Stavrou D; Rosen EM; Lamszus K
    Int J Cancer; 1999 Feb; 84(1):10-8. PubMed ID: 9988225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of hepatocyte growth factor in smooth muscle cells regulates endothelial progenitor cells differentiation, migration and proliferation.
    Zhu G; Huang L; Song M; Yu Z; Wu X; Zhao X; Jin J; Zhao G; Chen J; Yu S
    Int J Cardiol; 2010 Jan; 138(1):70-80. PubMed ID: 19095317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
    Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
    Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.